University of Cambridge

The University of Cambridge unites experts, industry partners, world-class facilities and unique clinical data to enable global leadership in early cancer detection, prediction and interception.

About the centre

The University of Cambridge has been a member of the International Alliance for Cancer Early Detection (ACED) since its launch in 2019.

The ACED centre at the University of Cambridge is embedded within the broader Cancer Research UK Cambridge Centre, whose basic, translational and clinical research is delivered through eight foundational research programmes, five virtual institutes and three affiliated physical institutes. These include the Cancer Research UK Cambridge Institute and the Early Cancer Institute (ECI), ensuring that ACED’s work is integrated into the wider cancer research ecosystem in Cambridge. ACED is also aligned with the ECI’s mission to improve cancer risk prediction, diagnosis and interception.

This ecosystem attracts and develops talented researchers by offering an inclusive environment, excellent training opportunities and support for career progression. Clinician scientists can also access targeted support through the Integrated Academic Training Programme to help them build successful careers spanning both research and clinical practice.

Learn more about the University of Cambridge

Professor Rebecca Fitzgerald.

Cambridge has a unique focus on early cancer within our dedicated Early Cancer Institute. Being part of ACED means that we can expand our network in this vital research area and pull together to train the next generation.

- Rebecca Fitzgerald, University of Cambridge ACED Centre Director

Core expertise and resources

  • advanced data acquisition and computational analytics to transform our understanding of cancer risk prediction and enable early interception of cancers

  • availability of large, well‑characterised clinical cohorts focused on early cancer detection

  • high-resolution longitudinal T cell receptor repertoires for healthy individuals across diverse timepoints, providing an essential baseline of healthy repertoire dynamics

  • a unique biobank comprising matched normal tissue-tumour pairs and corresponding pre-diagnostic blood samples, integrated with neoantigen prediction frameworks

  • a partnership with the Cambridge Stem Cell Institute for spatial imaging and profiling

Key contacts

Professor Rebecca Fitzgerald.

Rebecca Fitzgerald

University of Cambridge ACED Centre Director

Steph Archer, University of Cambridge, Academic lead for ACED PPIE.

Stephanie Archer

University of Cambridge ACED Centre Deputy Director

Dr Bridget Bannerman.

Bridget Bannerman

University of Cambridge ACED Centre Programme Manager

Other member centres